DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Blueprint Report: Pharma BPO in the Emerging As-a-Service Economy Focus on R&D and Commercial Services" report to their offering.
This is the inaugural Pharmaceuticals Industry-Specific BPO Blueprint, presenting a comparative analysis of the innovation and execution capabilities of service providers in this market. The service providers in scope are multi-national, multi-functional service providers with industry-specific pharmaceuticals business process support capability in their portfolio.
This research looks at the evolution of Pharma BPO to As-a-Service-a market that is increasingly agile, collaborative, and consumer-centric. The Publisher considers this transition in outsourcing a move to the As-a-Service Economy, placing increasing value on diverse talent, analytics, and collaboration, as well as increasingly on platform-based services.
Thus, in this Blueprint we use the 8 Ideals of the As-a-Service Economy as a significant element of our service provider assessment methodology. The eight ideals describe the operations of service buyers and service buyers in a business outcome-focused outsourcing partnership.
Two of the significant ways that pharmaceuticals companies touch consumers are in the R&D process and through sales and marketing. Along these lines, the scope of the Blueprint is business process support for industry-specific Pharmaceutical Research & Development and Commercial Services, including clinical data management, pharmacovigilance, regulatory support, consumer experience management, and sales and marketing.
Key Topics Covered:
1. Executive Summary
2. Key Market Dynamics
3. Research Methodology
4. Service Provider Analysis
5. Market Direction and Recommendations
6. About the Author
For more information visit http://www.researchandmarkets.com/research/g9px4j/blueprint_report
